Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Rubius Therapeutics, Inc. (RUBY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Appelhans Dannielle (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 10,385 shares
@ $0.1274, valued at
$1.3k
|
|
| 02/01/2023 |
4
| CAGNONI PABLO J (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 8,448 shares
@ $0.25, valued at
$2.1k
|
|
| 02/01/2023 |
4
| Appelhans Dannielle (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 3,878 shares
@ $0.25, valued at
$969.5
Exercised 7,500 restricted stock units
@ $0 |
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Appelhans Dannielle (COO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 5,737 shares
@ $0.8, valued at
$4.6k
Exercised 12,500 restricted stock units
@ $0 |
|
| 08/01/2022 |
4
| Schaffert Susanne (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.702, valued at
$35.1k
|
|
| 05/13/2022 |
4
| Prener Anne (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.24, valued at
$31k
|
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $1.4443, valued at
$43.3k
|
|
| 02/01/2022 |
4
| CAGNONI PABLO J (CEO and President) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 6,730 shares
@ $6.573, valued at
$44.2k
Exercised 21,250 restricted stock units
@ $0
Granted 365,000 options to buy
@ $6.75, valued at
$2.5M
Granted 100,000 restricted stock units
@ $0 |
|
| 02/01/2022 |
4
| Carmona Jose (CFO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 143,750 options to buy
@ $6.75, valued at
$970.3k
Granted 34,500 restricted stock units
@ $0 |
|
| 02/01/2022 |
4
| Appelhans Dannielle (COO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $6.75, valued at
$843.8k
Granted 30,000 restricted stock units
@ $0 |
|
| 02/01/2022 |
4
| Keson-Brookes Maiken (CLO & Corp. Secretary) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 2,732 shares
@ $6.573, valued at
$18k
Exercised 8,075 restricted stock units
@ $0
Granted 143,750 options to buy
@ $6.75, valued at
$970.3k
Granted 34,500 restricted stock units
@ $0 |
|
| 02/01/2022 |
4
| Turka Laurence A. (Chief Scientific Officer) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 2,517 shares
@ $6.573, valued at
$16.5k
Exercised 7,438 restricted stock units
@ $0
Granted 143,750 options to buy
@ $6.75, valued at
$970.3k
Granted 34,500 restricted stock units
@ $0 |
|
| 09/01/2021 |
4
| Appelhans Dannielle (COO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $21.72, valued at
$3.3M
Granted 50,000 restricted stock units
@ $0 |
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|